HSTM Stock Analysis: Buy, Sell, or Hold?
HSTM - HealthStream Inc
$28.87
0.28 (0.98%)
▲
5d:
-0.24%
30d:
+9.4%
90d:
+21.97%
BUY
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 03, 2026
0d
Get Alerted When HSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HSTM shows positive signals but monitor for confirmation. Market pricing in 5.4% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: HSTM shows positive signals but monitor for confirmation. Market pricing in 5.4% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.76
Based on 12.6% avg growth
INTRINSIC VALUE TODAY
$24.69
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSTM is currently trading at $28.87, which is considered slightly high relative to its 30-day fair value range of $27.66 to $29.08. From a valuation perspective, the stock is trading at a premium (Forward PE: 32.6) compared to its historical average (27.8). At these levels, the market is pricing in 5.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HSTM is in a strong uptrend. Immediate support is located at $27.75, while resistance sits at $29.85.
Market Sentiment: HSTM scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $34.50 (+19.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HSTM is in a strong uptrend. Immediate support is located at $27.75, while resistance sits at $29.85.
Market Sentiment: HSTM scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $34.50 (+19.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$27.66 -
$29.08
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.9%
All Signals
- BULLISH: Strong technical setup (64/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($34.50)
- NEUTRAL: Trading at premium valuation - market expects 5.4% growth which is achievable
- BULLISH: Bottoming setup score 64/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$27.66 -
$29.08
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$27.75
Resistance Level
$29.85
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
32.62
Wall Street Target
$34.50
(+19.5%)
Revenue Growth (YoY)
12.5%
Earnings Growth (YoY)
28.4%
Profit Margin
6.6%
Valuation Premium vs History
+5.4% premium
PE vs Historical
32.6 vs 27.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.4%
(market-implied from PE analysis)
1-Year Target
$30.43
(+5%)
2-Year Target
$32.07
(+11%)
3-Year Target
$33.80
(+17%)
3-Yr Target (if PE normalizes)
(PE: 33→28)
PE COMPRESSION
$28.81
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 32.6, Growth: 21.2%)
$51.44
(+78%)
Base:
(SPY PE: 20.1, Growth: 21.2%)
$31.65
(+10%)
Bear:
(PE: 17.1, Growth: 21.2%)
$26.90
(-7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (40x PE), but valuation improves significantly next year (33x PE) as earnings recover.
Trailing PE: 39.71 | Current EPS (TTM): $0.72
Bull Case
$38.66
(+34%)
Analyst growth 22.9%, PE expands to 43.7
Base Case
$35.14
(+22%)
Market implied 22.9%, PE stable at 39.7
Bear Case
$19.44
(-33%)
Severe decline -20.0%, PE contracts to 33.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 3:28 PM ET
Data refreshes hourly during market hours. Next update: 4:28 PM
Data refreshes hourly during market hours. Next update: 4:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 33 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 37 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
12 analysts |
$79 | 63 BUY |
